Skip to main content

Moderna says COVID vaccine tweaked for South African variant is ready for testing

Moderna Inc. said Wednesday it has made the initial batch of doses of a new COVID-19 vaccine designed to better protect people against a new strain of the coronavirus that has shown some resistance to the company’s original vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.